DCF Tool

STE

Steris Plc – Surgical Appliance and Supplies Manufacturing
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Analysis Results
Intrinsic Value $416.23
Latest Price $231.34
Relative Value 44% undervalued
Thoughts on this result? Let us know.
Ad
Cash Flow (Billions)
Analysis Parameters
%
%
%
New Ticker
Ad
Analysis Details
Growth Rate Projection

An exponential growth model was fit to the past cash flow data, giving more weight to more recent years. This model determined a growth rate estimate of 24.8%.

Weighted Average Cost of Capital (WACC)

The calculated WACC is 7.7%. This value is used as the default discount rate.

Value of Future Flows

Assuming a growth rate of 24.8%, the cash flows for the next 5 years are projected.

The present value of each year's flow is adjusted to present value using the discount rate.

Year Future flow (billion) Present value (billion)
2024 1.2 1.11
2025 1.49 1.29
2026 1.86 1.49
2027 2.33 1.73
2028 2.9 2.01
Terminal Value

Assuming a growth rate after the projection years of 2.0%, the terminal value of the company would be 52.2 billion. This corresponds to a present value of 33.5 billion.

Intrinsic Value Per Share

The total present value of the projected cash flows is 7.63 billion. Adding in the terminal value gives a total present value of 41.1 billion.

There are presently 98.8 million outstanding shares, so the intrinsic value per share is 416.23.

Financial Statements

The following data was to determine the past cash flows.

Current Assets 2,011,442,000
Current Cash 208,357,000
Current Liabilities 861,844,000
Current Debt 60,000,000
Non-Cash Working Capital (NCWC) 1,001,241,000
Change in NCWC 249,911,000
EBIT 759,235,000
Tax Provision 51,535,000
Depreciation and Amortization 552,897,000
Capital Expenditure -361,969,000
Unlevered Free Cash Flow 951,407,504
Current Assets 1,878,997,000
Current Cash 348,320,000
Current Liabilities 922,222,000
Current Debt 142,875,000
Non-Cash Working Capital (NCWC) 751,330,000
Change in NCWC 338,027,000
EBIT 425,666,000
Tax Provision 71,633,000
Depreciation and Amortization 553,104,000
Capital Expenditure -287,563,000
Unlevered Free Cash Flow 932,281,880
Current Assets 1,211,754,000
Current Cash 220,531,000
Current Liabilities 577,920,000
Current Debt 0
Non-Cash Working Capital (NCWC) 413,303,000
Change in NCWC 27,740,000
EBIT 545,454,000
Tax Provision 120,663,000
Depreciation and Amortization 219,237,000
Capital Expenditure -239,262,000
Unlevered Free Cash Flow 425,996,209
Current Assets 1,208,751,000
Current Cash 319,581,000
Current Liabilities 503,607,000
Current Debt 0
Non-Cash Working Capital (NCWC) 385,563,000
Change in NCWC 17,657,000
EBIT 537,646,000
Tax Provision 90,876,000
Depreciation and Amortization 197,235,000
Capital Expenditure -214,516,000
Unlevered Free Cash Flow 440,045,301
Current Assets 1,053,735,000
Current Cash 220,633,000
Current Liabilities 465,196,000
Current Debt 0
Non-Cash Working Capital (NCWC) 367,906,000
Change in NCWC -21,755,000
EBIT 442,452,000
Tax Provision 64,394,000
Depreciation and Amortization 225,921,000
Capital Expenditure -189,715,000
Unlevered Free Cash Flow 379,789,150
Current Assets 989,657,000
Current Cash 201,534,000
Current Liabilities 398,462,000
Current Debt 0
Non-Cash Working Capital (NCWC) 389,661,000
Change in NCWC 36,360,000
EBIT 403,557,000
Tax Provision 63,360,000
Depreciation and Amortization 178,332,000
Capital Expenditure -165,457,000
Unlevered Free Cash Flow 380,761,949
Current Assets 1,017,802,000
Current Cash 282,918,000
Current Liabilities 381,583,000
Current Debt 0
Non-Cash Working Capital (NCWC) 353,301,000
Change in NCWC 30,223,000
EBIT 286,166,000
Tax Provision 74,015,000
Depreciation and Amortization 188,142,000
Capital Expenditure -172,901,000
Unlevered Free Cash Flow 216,920,899
Current Assets 972,525,000
Current Cash 248,841,000
Current Liabilities 400,606,000
Current Debt 0
Non-Cash Working Capital (NCWC) 323,078,000
Change in NCWC 53,666,000
EBIT 212,107,000
Tax Provision 60,299,000
Depreciation and Amortization 143,740,000
Capital Expenditure -126,407,000
Unlevered Free Cash Flow 208,696,281
Current Assets 720,432,000
Current Cash 167,689,000
Current Liabilities 283,331,000
Current Debt 0
Non-Cash Working Capital (NCWC) 269,412,000
Change in NCWC 1,975,000
EBIT 226,820,000
Tax Provision 73,756,000
Depreciation and Amortization 91,541,000
Capital Expenditure -85,255,000
Unlevered Free Cash Flow 154,967,333
Current Assets 674,745,000
Current Cash 152,802,000
Current Liabilities 254,506,000
Current Debt 0
Non-Cash Working Capital (NCWC) 267,437,000
Change in NCWC 14,342,000
EBIT 220,011,000
Tax Provision 58,934,000
Depreciation and Amortization 75,649,000
Capital Expenditure -86,367,000
Unlevered Free Cash Flow 154,803,894
Current Assets 613,940,000
Current Cash 142,008,000
Current Liabilities 218,837,000
Current Debt 0
Non-Cash Working Capital (NCWC) 253,095,000
Change in NCWC 30,428,000
EBIT 242,264,000
Tax Provision 67,121,000
Depreciation and Amortization 69,035,000
Capital Expenditure -87,412,000
Unlevered Free Cash Flow 182,711,542
Current Assets 651,883,000
Current Cash 150,821,000
Current Liabilities 278,395,000
Current Debt 0
Non-Cash Working Capital (NCWC) 222,667,000
Change in NCWC 54,623,000
EBIT 222,960,000
Tax Provision 74,993,000
Depreciation and Amortization 62,906,000
Capital Expenditure -66,682,000
Unlevered Free Cash Flow 194,603,751

This analysis is provided for informational purposes only and does not constitute financial or investing advice. For more information on the advantages and limitations of DCF analysis see background. This information is provided on an "as is" basis. No warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. By using this site you agree that under no circumstances shall Valuation Tools LLC be held liable for any loss or damage caused by information obtained from this website including any articles, data, videos, its social media accounts, or any other materials.